Gloriosa superba, a flowering plant widespread in South and Southeast Asia, is implicated in many cases of self-poisoning. Colchicine is concentrated in the seeds and tubers and this mediates its toxicity. We describe a 28-year-old woman who developed delayed encephalopathy after eating G superba tubers. MR scan of brain showed bilateral symmetrical T2 basal ganglia hyperintensities in the caudate and lentiform nuclei. The delay in onset of encephalopathy is attributable to a direct-effect colchicine, probably mediated through its effect on microtubular transport.
BACKGROUND
Gloriosa superba-the climbing lily-is a flowering plant (figure 1) found in equatorial countries, such as India and Sri Lanka. 1 It is one of the commonest selfingested plant poisons in Sri Lanka. 2 Poisoning can follow ingestion of seeds and tubers (figure 2), which contain the alkaloid compound colchicine. 3 Colchicine poisoning causes vomiting and diarrhoea, hepatic and renal failure and bone marrow toxicity, with pancytopenia and disseminated intravascular coagulation. 4 5 It can also alter neuromuscular function 6 and cause myotoxicity. 7 However, there are few data on the neurological manifestations of Gloriosa poisoning.
CASE REPORT
A 28-year-old woman, previously healthy, presented with abdominal pain, diarrhoea and profuse vomiting. Six hours before, she had eaten G superba tubers when attempting to end her life after a domestic dispute. On admission, she was stable; we gave activated charcoal and treated her symptomatically. After initially improving, on the 5th day she developed generalised tonic-clonic seizures. She was hypocalcaemic, with serum ionised calcium of 0.9 mmol/L (1.1-1.4). We gave intravenous calcium and anticonvulsants and achieved seizure control. On day 7, her level of consciousness declined to a Glasgow coma scale score of 6 out of 15. There were no focal neurological signs. Her full blood count, arterial blood gas tensions, urinalysis, erythrocyte sedimentation rate, serum C-reactive protein, urea, electrolytes, glucose, ammonia, calcium and magnesium were normal. Her serum transaminases were transiently mildly elevated: serum aspartate aminotransferase 278 U/L (1-31) and alanine aminotransferase 216 U/L (5-35). CT scan of head, lumbar puncture, ultrasound scan of pelvis and abdomen were normal. Serology for Epstein-Barr virus, cytomegalovirus, Japanese encephalitis (JE) virus, and herpes simplex virus were negative. EEG showed bilateral diffuse slow waves, suggestive of encephalopathy.
MR scan of her brain (figure 3) showed bilateral T2 hyperintensities in the basal ganglia. We managed her supportively in the intensive care unit. By day 15, her Glasgow coma scale score had improved to 11/15 and remained static up to the point of the current report. She also developed alopecia.
DISCUSSION
This case highlights a delayed toxic encephalopathy following Gloriosa poisoning. Based on the unequivocal history of ingestion of Gloriosa tubers, the extracentral nervous system clinical features supporting Gloriosa toxicity, the temporal profile of the onset of encephalopathy and the exclusion of other neoplastic, immune, infective and metabolic causes for encephalopathy, we conclude that her encephalopathy resulted from colchicine toxicity following Gloriosa tuber ingestion. However, we had no facilities to assess serum levels of colchicine. Patients with colchicine poisoning occasionally develop confusion and seizures, but all such cases have concomitant renal or liver dysfunction. 8 9 By contrast, our patient had no significant metabolic derangement. The other unusual feature of her encephalopathy was the delayed onset, reminiscent of that following anoxic encephalopathy and carbon monoxide poisoning. 10 MR brain scan findings of bilateral T2 hyper intensities in the caudate and lentiform nuclei of the basal ganglia in this patient are consistent with a toxic encephalopathy, further strengthening the case for a Gloriosa-induced encephalopathy ( figure 3) . The thalamic regions were unaffected. The putamen and globus pallidus of the basal ganglia have abundant mitochondria, neurotransmitter and chemical content. They are also extremely metabolically active and are exceedingly prone to metabolic and toxic damage. 11 The basal ganglia lesions in toxic and metabolic encephalopathies are global and symmetrical, as in this patient. Furthermore, similar isolated basal ganglia lesions without concomitant thalamic involvement occur with only a few causes of toxic encephalopathy, such as hyperammonaemia and hypoglycaemia 11 : we excluded both these in this patient. Infectious disease can also cause basal ganglia abnormalities, but such lesions are usually more asymmetrical and patchy. It is also possible that she had ingested another neurotoxic agent along with the G superba.
Gloriosa's active toxic compound is the alkaloid colchicine, which binds to tubulin and inhibits its polymerisation into microtubules. Colchicine's toxic effects are mediated through microtubule disruption, which, in neural cells, interferes with axonal and dendritic transmission. In experimental and animal models, colchicine causes the neuronal cell death of certain neuronal populations, such as the granular cells of the dentate gyrus and pyramidal cells of the hippocampus. Colchicine may induce an autotoxic response, leading to neuronal death of certain populations, including the basal ganglia, due to the accumulation of a toxic cellular product which is normally transported by a microtubule-dependent process. 12 This may be the explanation for the delayed onset of this patient's encephalopathy, as a time lag may be evident before a critical neuronal toxic concentration of these substances is reached. The concentration of colchicine in cerebral tissue is usually low following poisoning, perhaps explaining why, despite these experimental findings, clinical cases of colchicine poising are so rare.
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